YKST-02

N/A

Report date: 2026/05/13 20:02:10

Base Information

Drug NameYKST-02
Drug Alias NameYKST02YKST-02
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionAnti-BCMAAnti-CD3
TargetsB-cell maturation proteinT cell surface glycoprotein CD3
Therapy Area/IndicationsLupus Erythematosus, SystemicGlomerulonephritis, IGAMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesExcyte Biopharma Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesExcyte Biopharma LtdWuhan Union Hospital
Inactive CompaniesN/A
Active IndicationsLupus Erythematosus, SystemicGlomerulonephritis, IGAMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A